Our INSPECT-Crypto
Project

Deciphering the immuno-pathophysiology of cryptococcal disease across the spectrum

Our INSPECT-Crypto
Project

Deciphering the immuno-pathophysiology of cryptococcal disease across the spectrum

Project Overview

Project title: Deciphering the immuno-pathophysiology of cryptococcal disease across the spectrum

Abbreviation: Immuno-pathophysiology in the spectrum of cryptococcal disease (INSPECT-Crypto)

The INSPECT-Crypto project aims to elucidate the changes in predominant biomarkers of inflammation and brain injury in blood and CSF of patients along the spectrum of HIV-associated cryptococcal infection and disease. It is a mixed cross-sectional retrospective and prospective cohort study of 200 participants (5 groups of 40 per group) along the spectrum of cryptococcal infection/ disease.

Key Objectives

Primary Outcomes

The primary objective of the study is to elucidate the changes in predominant biomarkers of inflammation and brain injury in blood and CSF of patients along the spectrum of HIV-associated cryptococcal infection and disease.

Secondary Objectives
  • To characterise the phenotypic stages of cryptococcal infection
  • To identify potential targets for immunotherapy in cryptococcal infection
  • To identify serum biomarkers which signify risk of central nervous system infection, and which could be used as supplements to semi-quantitative cryptococcal antigen (SQ CrAg) testing where lumbar puncture/ CSF analysis is not available.
Exploratory Objectives
  • Neuroimaging sub-study to identify changes to CSF flow and cryptococcal aggregation.

Achievements

Protocol approved by UCT HREC, UCT Faculty of Health Sciences Biosafety Committee, and Western Cape Department of Health. Not yet open to recruitment.

Current Status

2026

Not yet open to recruitment pending a protocol amendment.

Recruitment / Site Participation

Not yet started, pending a protocol amendment which will include additional sites outside of Cape Town.

Team Members

  • Dr Kyla Murphy (Clinical)
  • Dr Rachael Dangarembizi (Laboratory)
  • Dr Asha Thombrayil
  • Dr Teagan van Wyk
  • Dr Juliet Rundogo
  • Dr Lia Edkins
  • Dr Danielle Verhagen
  • Dr Isabella Fatti
  • Dr Mxolisi Xulu
  • Prof. Graeme Meintjes
  • Dr Rachel Wake
  • Prof. Suzaan Marais
  • Dr Síle Molloy
  • Prof. Nelesh Govender
  • Prof. Thomas Harrison
  • Prof. Joseph Jarvis
  • Dr David Lawrence
  • Sr Paulina Mbutuma
  • Sr Ntwenhle Makhaza
  • Sr Lethukuthula Zondi
  • Sr Juliet Kortrooi
  • Sr Thobeka Lebenya

Media

First samples from EFFECT and Sub-EFFECT being processed in Dr Dangarembizi’s lab for generation of pilot data